EEosaühing Farmax
About the company
The company osaühing Farmax (reg. no. 10134049) was registered on 07.10.1996. Registered address: Tartu maakond, Tartu linn, Tartu linn, Jaama tn 56. Main industry: Professional, scientific and technical activities. In 2025, revenue was 617 189 EUR and profit 9 385 EUR. Revenue change compared with 2024: +6,0%. Employees: 10 (2025). The company is a registered VAT payer. Regmio risk score: 40 out of 100 — high risk.
Financials by year
| Year | Turnover | Net profit | Employees |
|---|---|---|---|
| 2025 | 617 189 EUR | 9 385 EUR | 10 |
| 2024 | 582 193 EUR | 5 799 EUR | 10 |
| 2023 | 555 841 EUR | 10 232 EUR | 9 |
| 2022 | 529 353 EUR | 5 345 EUR | 10 |
| 2021 | 526 161 EUR | 13 256 EUR | 10 |
| 2020 | 579 141 EUR | 12 325 EUR | 10 |
Activity
75001 Veterinaaria
Frequently asked questions about osaühing Farmax
When was osaühing Farmax registered?
osaühing Farmax was registered on 07.10.1996, registration number 10134049.
Is osaühing Farmax active?
Yes, according to the register the company is active (not removed from the register).
What is the registered address of osaühing Farmax?
Registered address: Tartu maakond, Tartu linn, Tartu linn, Jaama tn 56.
Is osaühing Farmax VAT registered?
Yes, VAT number: EE100013243. Validity for cross-border transactions can be checked in EC VIES.
What does osaühing Farmax do?
Main industry: Professional, scientific and technical activities.
What is the turnover of osaühing Farmax?
In 2025, revenue was 617 189 EUR.
How many employees does osaühing Farmax have?
Employees: 10 (2025).
Who manages and owns osaühing Farmax?
The registers list 2 officers and 6 owners or beneficial owners. Names and shares are in the full profile.
Full profile available after login
Free account — 3 full profiles per month. Log in with an e-mail code, no password.
- Board and authorised representatives 2
- Owners and beneficial owners 6
- Financial indicators 7
- Tax and VAT
- Legal events and restrictions
- Timeline 29
Data from official public registers · updated 15.11.2026. Data sources and disclaimer